223 related articles for article (PubMed ID: 35723978)
1. SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation.
Nguyen HL; Thai NQ; Nguyen PH; Li MS
J Phys Chem B; 2022 Jun; 126(25):4669-4678. PubMed ID: 35723978
[TBL] [Abstract][Full Text] [Related]
2. Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence.
Kumar R; Murugan NA; Srivastava V
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328828
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into the binding interactions and energetics of the omicron spike variant with hACE2 and a neutralizing antibody.
Kumar V; Shefrin S; Sundar D
J Struct Biol; 2024 Jun; 216(2):108087. PubMed ID: 38494148
[TBL] [Abstract][Full Text] [Related]
4. Investigating the role of glycans in Omicron sub-lineages XBB.1.5 and XBB.1.16 binding to host receptor using molecular dynamics and binding free energy calculations.
Singh JK; Singh J; Srivastava SK
J Comput Aided Mol Des; 2023 Nov; 37(11):551-563. PubMed ID: 37542610
[TBL] [Abstract][Full Text] [Related]
5. Binding Interactions between Receptor-Binding Domain of Spike Protein and Human Angiotensin Converting Enzyme-2 in Omicron Variant.
Jawad B; Adhikari P; Podgornik R; Ching WY
J Phys Chem Lett; 2022 May; 13(17):3915-3921. PubMed ID: 35481766
[TBL] [Abstract][Full Text] [Related]
6. Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant.
Wang WB; Ma YB; Lei ZH; Zhang XF; Li J; Li SS; Dong ZY; Liang Y; Li QM; Su JG
J Mol Graph Model; 2023 Nov; 124():108540. PubMed ID: 37352723
[TBL] [Abstract][Full Text] [Related]
7. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants.
da Costa CHS; de Freitas CAB; Alves CN; Lameira J
Sci Rep; 2022 May; 12(1):8540. PubMed ID: 35595778
[TBL] [Abstract][Full Text] [Related]
8. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.
Kumar S; Karuppanan K; Subramaniam G
J Med Virol; 2022 Oct; 94(10):4780-4791. PubMed ID: 35680610
[TBL] [Abstract][Full Text] [Related]
9. Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2.
Celik I; Khan A; Dwivany FM; Fatimawali ; Wei DQ; Tallei TE
Mol Divers; 2022 Dec; 26(6):3309-3324. PubMed ID: 35138508
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain.
Pitsillou E; Liang JJ; Beh RC; Hung A; Karagiannis TC
Comput Biol Med; 2022 Oct; 149():106035. PubMed ID: 36055162
[TBL] [Abstract][Full Text] [Related]
11. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies.
Shah M; Woo HG
Front Immunol; 2021; 12():830527. PubMed ID: 35140714
[TBL] [Abstract][Full Text] [Related]
12. Investigation on the interaction mechanism of different SARS-CoV-2 spike variants with hACE2: insights from molecular dynamics simulations.
Wu J; Zhang HX; Zhang J
Phys Chem Chem Phys; 2023 Jan; 25(3):2304-2319. PubMed ID: 36597957
[TBL] [Abstract][Full Text] [Related]
13. Omicron Binding Mode: Contact Analysis and Dynamics of the Omicron Receptor-Binding Domain in Complex with ACE2.
Fazekas Z; Menyhárd DK; Perczel A
J Chem Inf Model; 2022 Aug; 62(16):3844-3853. PubMed ID: 35849759
[TBL] [Abstract][Full Text] [Related]
14. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 omicron RBD forms a weaker binding affinity to hACE2 compared to Delta RBD in
Le HT; Tran LH; Phung HTT
J Biomol Struct Dyn; 2024 May; 42(8):4087-4096. PubMed ID: 37345564
[TBL] [Abstract][Full Text] [Related]
16. DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach.
Silwal AP; Thennakoon SKS; Arya SP; Postema RM; Jahan R; Phuoc CMT; Tan X
Theranostics; 2022; 12(12):5522-5536. PubMed ID: 35910791
[No Abstract] [Full Text] [Related]
17. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
[TBL] [Abstract][Full Text] [Related]
18. Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods.
Ebrahimi M; Karami L; Alijanianzadeh M
Comput Biol Med; 2022 Aug; 147():105709. PubMed ID: 35728285
[TBL] [Abstract][Full Text] [Related]
19. Structural bioinformatics analysis of SARS-CoV-2 variants reveals higher hACE2 receptor binding affinity for Omicron B.1.1.529 spike RBD compared to wild type reference.
Durmaz V; Köchl K; Krassnigg A; Parigger L; Hetmann M; Singh A; Nutz D; Korsunsky A; Kahler U; König C; Chang L; Krebs M; Bassetto R; Pavkov-Keller T; Resch V; Gruber K; Steinkellner G; Gruber CC
Sci Rep; 2022 Aug; 12(1):14534. PubMed ID: 36008461
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
